These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 12750759

  • 1. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
    Rodríguez-Zurita ME, Solís del Baño S, Robres Guillén P, González Praetorius A, Gimeno Fernández C, Pérez Pomata MT, Bisquert Santiago J.
    Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
    Bejuk D.
    Acta Med Croatica; 2004 Mar; 58(4):301-6. PubMed ID: 15700686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
    Colakoglu S, Alacam R, Hascelik G.
    Scand J Infect Dis; 2006 Mar; 38(6-7):456-9. PubMed ID: 16798693
    [Abstract] [Full Text] [Related]

  • 7. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
    Kaya EG, Yücel M, Karakoç AE.
    Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
    [Abstract] [Full Text] [Related]

  • 8. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
    Limia A, Jiménez ML, Delgado T, Sánchez I, López S, López-Brea M.
    Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
    [Abstract] [Full Text] [Related]

  • 9. Resistance to macrolides, clindamycin and telithromycin in Streptococcus pyogenes isolated in Spain during 2004.
    Tamayo J, Pérez-Trallero E, Gómez-Garcés JL, Alós JI, Spanish Group for the Study of Infection in the Primary Health Care Setting.
    J Antimicrob Chemother; 2005 Oct; 56(4):780-2. PubMed ID: 16120627
    [Abstract] [Full Text] [Related]

  • 10. Resistance to erythromycin and rising penicillin MIC in Streptococcus pyogenes in India.
    Capoor MR, Nair D, Deb M, Batra K, Aggarwal P.
    Jpn J Infect Dis; 2006 Oct; 59(5):334-6. PubMed ID: 17060703
    [Abstract] [Full Text] [Related]

  • 11. Inducible clindamycin resistance in staphylococci isolated from clinical samples.
    Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G.
    Jpn J Infect Dis; 2005 Apr; 58(2):104-6. PubMed ID: 15858290
    [Abstract] [Full Text] [Related]

  • 12. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
    Soriano SV, Brasili S, Saiz M, Carranza C, Vidal P, Calderón J, Lopardo HA.
    Medicina (B Aires); 2000 Apr; 60(4):487-90. PubMed ID: 11188957
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility patterns and macrolide resistance genes of beta-hemolytic streptococci in Korea.
    Uh Y, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2716-8. PubMed ID: 15215133
    [Abstract] [Full Text] [Related]

  • 14. [Macrolide resistance phenotypes and genotypes in group G streptococci].
    Açikgöz ZC, Göçer S, Almayanlar E.
    Mikrobiyol Bul; 2003 Jul; 37(2-3):117-24. PubMed ID: 14593892
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and mechanisms of erythromycin and clindamycin resistance in clinical isolates of beta-haemolytic streptococci of Lancefield groups A, B, C and G in Seville, Spain.
    Merino Díaz L, Torres Sánchez MJ, Aznar Martín J.
    Clin Microbiol Infect; 2008 Jan; 14(1):85-7. PubMed ID: 18034859
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE, Wagner J, Arvand M.
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [Abstract] [Full Text] [Related]

  • 17. [Resistance phenotypes and genotypes of Streptococcus pyogenes clinical isolates in Chile over a 10-year period].
    Rodríguez C, Rojas P, Wozniak A, Kalergis AM, Cerón I, Riedel I, Román JC, Villarroel LA, Berríos X, Bavestrello L, García P.
    Rev Med Chil; 2011 Sep; 139(9):1143-9. PubMed ID: 22215392
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
    Uh Y, Shin DH, Jang IH, Hwang GY, Lee MK, Yoon KJ, Kim HY.
    J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).
    Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martín R, Liñares J.
    J Antimicrob Chemother; 2010 Apr; 65(4):634-43. PubMed ID: 20118164
    [Abstract] [Full Text] [Related]

  • 20. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.
    Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.
    Clin Infect Dis; 2005 Sep 01; 41(5):599-608. PubMed ID: 16080080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.